We are live on ! Find out more
NGEN

NervGen Pharma
NGEN

45 hedge funds and large institutions have $6.42M invested in NervGen Pharma in 2026 Q1 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

11,370% more capital invested

Capital invested by funds: $56K → $6.42M (+$6.37M)

4,400% more funds holding

Funds holding: 1 → 45 (+44)

2.1% more ownership

Funds ownership: 0% → 2.1% (+2.1%)

Holders
45
Holders Change
+44
Holders Change %
+4,400%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
–
Reduced
–
Closed
–
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$7K

Top Buyers

Rank Fund Capital Flow
1
PI
PFG Investments
New York
+$871K
2
Bank of America
Bank of America
North Carolina
+$869K
3
Marshall Wace
Marshall Wace
United Kingdom
+$868K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$745K
5
IWC
Integrated Wealth Concepts
Massachusetts
+$376K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
1
PFG Investments
New York
$758K +$871K +201,000 New
Bank of America
2
Bank of America
North Carolina
$756K +$869K +200,656 New
Marshall Wace
3
Marshall Wace
United Kingdom
$755K +$868K +200,359 New
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$648K +$745K +171,961 New
IWC
5
Integrated Wealth Concepts
Massachusetts
$327K +$376K +86,815 New
VFIC
6
Valley Forge Investment Consultants
Pennsylvania
$293K +$337K +77,698 New
Bank of Montreal
7
Bank of Montreal
Ontario, Canada
$237K +$272K +62,900 New
CAPTRUST Financial Advisors
8
CAPTRUST Financial Advisors
North Carolina
$235K +$270K +62,367 New
UBS Group
9
UBS Group
Switzerland
$232K +$266K +61,517 New
Osaic Holdings
10
Osaic Holdings
Arizona
$151K +$173K +39,991 New
PFGIA
11
Patriot Financial Group Insurance Agency
Massachusetts
$139K +$160K +37,000 New
Commonwealth Equity Services
12
Commonwealth Equity Services
Massachusetts
$126K +$144K +33,350 New
Cetera Investment Advisers
13
Cetera Investment Advisers
Illinois
$118K +$136K +31,400 New
MCWS
14
McKinley Carter Wealth Services
West Virginia
$116K +$134K +30,892 New
TWC
15
TD Waterhouse Canada
Ontario, Canada
$103K +$103K +23,800 New
TCM
16
Traynor Capital Management
Pennsylvania
$95.1K +$110K +25,500 New
BB
17
Busey Bank
Illinois
$94.3K +$108K +25,000 New
SI
18
Sprott Inc
Ontario, Canada
$94.3K +$108K +25,000 New
LWM
19
Liberty Wealth Management
California
$82.9K +$95.3K +22,000 New
HF
20
HRT Financial
New York
$80K +$92.6K +21,366 New
GVAG
21
Great Valley Advisor Group
Delaware
$79.2K +$91K +21,000 New
AIP
22
Almanack Investment Partners
Pennsylvania
$78.9K +$90.6K +20,925 New
JP Morgan Chase
23
JP Morgan Chase
New York
$78.6K +$58.3K +13,462 New
Envestnet Asset Management
24
Envestnet Asset Management
Illinois
$75.4K +$86.6K +20,000 New
AAP
25
Arax Advisory Partners
Colorado
$68K +$78.1K +18,028 New
1
2

NGEN Hedge Fund Activity: Q1 2026 in Review

45 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in NervGen Pharma (NGEN) for Q1 2026, worth a combined $6.42M — up 11,370% from $56K a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new NGEN positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was PFG Investments, opening a new position worth an estimated $871K.

  • 45 institutional investors held NervGen Pharma (NGEN) as of Q1 2026, up from 1 in Q4 2025.
  • Funds reported $6.42M of NervGen Pharma stock for Q1 2026, up 11,370% quarter-over-quarter.
  • 44 funds opened new NervGen Pharma positions in Q1 2026 and 0 closed out, a net change of +44 holders.
  • The largest NervGen Pharma buyer in Q1 2026 was PFG Investments, an estimated $871K added.

Based on aggregated 13F filings for Q1 2026.